Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.45 |
| ▸ | HPGD | P15428 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 5/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.45 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 6/20 | 0.39 |
| ▸ | MEN1 | O00255 | 6/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL638575 | 1.00 | ALDH1A1 (0.45) | ALDH1A1HSD17B10HPGDTSHRCYP1A2 | |
| SCHEMBL638576 | 1.00 | ALDH1A1 (0.45) | ALDH1A1HSD17B10HPGDTSHRCYP1A2 | |
| SCHEMBL12486765 | 0.92 | ALDH1A1 (0.50) | ALDH1A1HSD17B10HPGDTSHRCYP1A2 | |
| SCHEMBL12486766 | 0.92 | ALDH1A1 (0.50) | ALDH1A1HSD17B10HPGDTSHRCYP1A2 | |
| SCHEMBL2935054 | 0.92 | ALDH1A1 (0.50) | ALDH1A1HSD17B10HPGDTSHRCYP1A2 | |
| SCHEMBL7638515 | 0.84 | ALDH1A1 (0.36) | ALDH1A1HSD17B10HPGDTSHRCYP1A2 | |
| SCHEMBL15848326 | 0.84 | ALDH1A1 (0.36) | ALDH1A1HSD17B10HPGDTSHRCYP1A2 | |
| SCHEMBL7618335 | 0.84 | ALDH1A1 (0.36) | ALDH1A1HSD17B10HPGDTSHRCYP1A2 | |
| SCHEMBL7638518 | 0.84 | ALDH1A1 (0.36) | ALDH1A1HSD17B10HPGDTSHRCYP1A2 | |
| SCHEMBL11129011 | 0.80 | ALDH1A1 (0.37) | ALDH1A1HSD17B10HPGDTSHRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12084649-B2 | Hierarchical magnetic nanoparticle-enzyme mesoporous assemblies embedded in macroporous scaffolds | CORNELL UNIVERSITY (US) | 2024-09-10 | — | — | US | disclosed |
| EP-2903734-B1 | ENZYMES FORMING MESOPOROUS ASSEMBLIES EMBEDDED IN MACROPOROUS SCAFFOLDS | UNIV CORNELL (US) | 2023-12-20 | — | — | EP | disclosed |
| US-11753222-B2 | Powdered pouch and method of making same | MONOSOL, LLC (US) | 2023-09-12 | — | — | US | disclosed |
| US-20230159979-A1 | TRANSDUCERS, NANOPARTICLE TRANSDUCER DEVICES AND SYSTEMS, AND RELATED METHODS OF USE | UNIVERSITY OF WASHINGTON (US) | 2023-05-25 | — | — | US | disclosed |
| EP-2825624-B2 | WATER SOLUBLE COMPOSITIONS INCORPORATING ENZYMES, AND METHOD OF MAKING SAME | MONOSOL LLC (US) | 2022-07-27 | — | — | EP | disclosed |
| US-20220213464-A1 | HIERARCHICAL MAGNETIC NANOPARTICLE-ENZYME MESOPOROUS ASSEMBLIES EMBEDDED IN MACROPOROUS SCAFFOLDS | CORNELL UNIVERSITY (US) | 2022-07-07 | — | — | US | disclosed |
| EP-2838811-B2 | POWDERED POUCH AND METHOD OF MAKING SAME | MONOSOL LLC (US) | 2022-06-29 | — | — | EP | disclosed |
| US-11236322-B2 | Enzyme forming mesoporous assemblies embedded in macroporous scaffolds | CORNELL UNIVERSITY (US) | 2022-02-01 | — | — | US | disclosed |
| EP-3354716-A1 | WATER SOLUBLE COMPOSITIONS INCORPORATING ENZYMES, AND METHOD OF MAKING SAME | Monosol, LLC (US) | 2018-08-01 | — | — | EP | disclosed |
| US-20150240226-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | BP CORP NORTH AMERICA INC (US) | 2015-08-27 | — | — | US | disclosed |
| US-8962800-B2 | Nucleic acids and proteins and methods for making and using them | BP CORPORATION NORTH AMERICA INC. (US) | 2015-02-24 | — | — | US | disclosed |
| US-20120266329-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | BP CORPORATION NORTH AMERICA INC. (US) | 2012-10-18 | — | — | US | disclosed |
| US-8119385-B2 | Nucleic acids and proteins and methods for making and using them | BP CORPORATION NORTH AMERICA INC. (US) | 2012-02-21 | — | — | US | disclosed |
| US-20110296543-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | THE UNIVERSITY OF CALIFORNIA (US) | 2011-12-01 | — | — | US | disclosed |
| US-20100011456-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | VERENIUM CORPORATION (US) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150240226-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | POLN, POLM, POLI | ALDH1A1 2292/4885HSD17B10 2323/4885HPGD 2170/4885 |
| US-20120266329-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | POLN, POLM, POLI | ALDH1A1 2292/4885HSD17B10 2323/4885HPGD 2170/4885 |
| US-20100011456-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | POLN, POLM, POLI | ALDH1A1 2292/4885HSD17B10 2323/4885HPGD 2170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.